These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11210353)

  • 1. [Therapy of patients with chronic pancreatitis of alcoholic etiology by dalagrin and laser therapy of the blood].
    Bulychev VF; Vakhrushev IaM
    Klin Med (Mosk); 2000; 78(12):43-6. PubMed ID: 11210353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Skomarovskiĭ ATs; Zemskov VS; Skomarovskiĭ AA
    Klin Khir; 1996; (8):13-4. PubMed ID: 9064131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transcranial electrostimulation combined with dalargin ultraphonophoresis in the treatment of patients with chronic idiopathic eczema].
    Iakushkina NIu; Silina LV; Zav'ialov AV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):25-7. PubMed ID: 16149414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
    Pobuts'kyĭ OO
    Klin Khir; 2002 Jan; (1):26-9. PubMed ID: 11944292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of dalargin for treating recurrent aphthous stomatitis].
    Maksimovskaia LN
    Stomatologiia (Mosk); 1995; 74(4):15. PubMed ID: 7502297
    [No Abstract]   [Full Text] [Related]  

  • 7. [The efficacy of using dalargin electrophoresis in the combined treatment of patients with ischemic heart disease].
    Ilaev TM; Ratner ZG
    Lik Sprava; 1998; (2):74-7. PubMed ID: 9670662
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of synthetic opioid peptide dalargin in acute myocardial infarction].
    Golikov AP; Riabinin VA; Zholudev AA; Luk'ianov MM; Avilova OA
    Kardiologiia; 1990 Sep; 30(9):24-7. PubMed ID: 2273732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Features of diagnosis and treatment of fatty pancreatic necrosis].
    Georgadze AK; Buzenkov SV; Dzhikia AA; Karpov VI
    Khirurgiia (Mosk); 1991 Apr; (4):90-5. PubMed ID: 2062078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dalargin in the prevention of acute postoperative pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Pomelov VS; Shloznikov BM; Karelin AA
    Klin Khir (1962); 1989; (11):9-12. PubMed ID: 2640568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endonasal electrophoresis of dalargin in the therapy of multiple and giant duodenal ulcers].
    Buglak NP; Kostiukova EA; Asanova LK; Moshko IuA
    Lik Sprava; 2003 Dec; (8):102-3. PubMed ID: 14965021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of dalargin as a component of postoperative analgesia in middle-aged and aged persons].
    Malyshev VD; Slastnikov SV; Sviridov SV; Bocharov VA; Mel'nik OB; Kasimov AO
    Anesteziol Reanimatol; 1995; (1):66-8. PubMed ID: 7605044
    [No Abstract]   [Full Text] [Related]  

  • 14. [A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area].
    Bazhanov NN; Ganina SS; Ragimov ChR; Pashutin SB; Brusina LI
    Stomatologiia (Mosk); 1993; 72(4):22-5. PubMed ID: 8108814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological and clinical evaluation of the effectiveness of dalargin in the treatment of arterial occlusive diseases of the lower extremities].
    Zoloev GK; Dudko VA; Sokolovich GE; Poiarkov VD; Ponurovskiĭ ; Beloglazov ME; Ivatsin NP; Stepanian NA; Shil'nikov MG
    Kardiologiia; 1990 Jul; 30(7):77-9. PubMed ID: 2232471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropeptides in the treatment of sensorineural hypoacusis in children].
    Pudov VI; Grigor'eva IF; Atamanova NV; Boronev SA
    Vestn Otorinolaringol; 1998; (4):22-4. PubMed ID: 9752091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier.
    Schroeder U; Sommerfeld P; Sabel BA
    Peptides; 1998; 19(4):777-80. PubMed ID: 9622035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The reinfusion of blood and the administration of dalargin in experimental hemorrhagic shock].
    Sherman DM; Trach VM
    Klin Khir (1962); 1994; (9):38-41. PubMed ID: 7602944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of an analog of endogenous opioids, dalargin, on the structure and function of the exocrine tissue of the pancreas in experimental acute pancreatitis].
    Georgadze AK; Permiakov NK; Vinogradov VA; Penin VA; Titova GP
    Farmakol Toksikol; 1985; 48(5):101-4. PubMed ID: 2416590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphofunctional changes in the pancreas in response to dalargin under normal conditions and in experimental pancreatitis].
    Kurzanov AN; Titova GP; Vinogradov VA; Aleĭnik VA; Gerasimov NF
    Biull Eksp Biol Med; 1988 Apr; 105(4):445-7. PubMed ID: 3359026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.